Results 41 to 50 of about 151,121 (186)

Mild Illness during Outbreak of Shiga Toxin−Producing Escherichia coli O157 Infections Associated with Agricultural Show, Australia

Emerging Infectious Diseases, 2017
During a large outbreak of Shiga toxin−producing Escherichia coli illness associated with an agricultural show in Australia, we used whole-genome sequencing to detect an IS1203v insertion in the Shiga toxin 2c subunit A gene of Shiga toxin−producing E ...
Bhakti R. Vasant, Russell J. Stafford, Amy V. Jennison, Sonya M. Bennett, Robert J. Bell, Christine J. Doyle, Jeannette R. Young, Susan A. Vlack, Paul Titmus, Debra El Saadi, Kari A.J. Jarvinen, Patricia Coward, Janine Barrett, Megan Staples, Rikki M.A. Graham, Helen V. Smith, Stephen B. Lambert   +16 more
doaj   +1 more source

Neonatal hemolytic uremic syndrome after mother-to-child transmission of a low virulent stx2b harbouring Shiga-toxin producing Escherichia coli [PDF]

, 2013
This case describes evidence for a Shiga toxin-producing Escherichia coli (STEC) O146:H28 infection leading to hemolytic uremic syndrome in a neonate. STEC O146:H28 was linked hitherto with asymptomatic carriage in humans. Based on strain characteristics
Kottanattu, Lisa, Tschumi, Sibylle, Steinmann, Markus, Simonetti, Giacomo D, Hächler, Herbert, Stephan, Roger; https://orcid.org/, von Steiger, Niklaus, Bucher, Barbara, Bucher, Barbara S, Stritt, Andrea, Stephan, Roger, Tschumi S, Stritt A, von Steiger N, Stephan R, Steinmann M, Kottanattu L, Hächler H, Simonetti GD, Bucher BS   +19 more
core   +2 more sources

Gut Health in Ostriches (Struthio camelus): Insights Into Intestinal Structure, Functions, Microbiome, and Improvement Strategies

Animal Research and One Health, EarlyView.
Our paper systematically reviews the intestinal structure, function, and microbiota of ostriches, along with strategies for improving their gut health. We analyze how these factors collectively influence intestinal homeostasis and ostrich welfare, emphasizing probiotics as a promising intervention to enhance gut health, boost population well‐being, and
Zi‐Qun Zhang, Fang‐Fang Guo, Wen‐Juan Du, Meng Li, Aftab Shaukat, Zhu‐Qing Jia, Shu‐Cheng Huang   +6 more
wiley   +1 more source

Research advances in the mechanisms of indoxyl sulfate and sarcopenia in chronic kidney disease

Linchuang shenzangbing zazhi
Sarcopenia in chronic kidney disease （CKD） occurs mainly in patients with end-stage renal disease （ESRD） on hemodialysis. The potential causes are insufficient nutrition intake, protein and energy consumption, inflammatory cytokines, oxidative stress ...
Shu-yuan Yang, Yan Zhang, Yan-kun Luo
doaj   +1 more source

Hypertension in obesity: A focus on individualized pharmacotherapy and the role of body composition, on behalf of the European Society of Hypertension Working Group on Diabetes and Metabolic Risk Factors and Working Group on Lifestyle, Cardiovascular Pharmacotherapy and Adherence

British Journal of Clinical Pharmacology, EarlyView.
Hypertension in obesity represents a major global health challenge, closely linked to the global epidemics of obesity, type 2 diabetes and metabolic dysfunction. Excess adiposity contributes to elevated blood pressure through multiple, interrelated mechanisms, including activation of the renin–angiotensin–aldosterone system, sympathetic nervous system ...
Christina Antza, Andrej Belancic, Jens Jordan, Alberto Esteban, Anna Oliveras, Ryan McNally, Panagiota Anyfanti, Jorie Versmissen, María S. Fernández‐Alfonso, Vasilios Kotsis, Thomas Weber, Alexandre Persu, Reinhold Kreutz   +12 more
wiley   +1 more source

Correlation Between Indoxyl Sulfate in Chronic Kidney Disease and Olfactory Dysfunction [PDF]

Iranian Journal of Otorhinolaryngology
Introduction: Olfactory dysfunction is prevalent among individuals with chronic kidney disease (CKD), with prevalence escalating alongside disease severity.
Irnanda Nasution, Tengku Siti Haryuna, Delfitri Munir, Syafrizal Nasution, Putri Eyanoer, Siti Nursiah, Ramlan Sitompul   +6 more
doaj   +1 more source

Nrf2 Activation in Chronic Kidney Disease: Promises and Pitfalls

Antioxidants, 2022
The nuclear factor erythroid 2-related factor 2 (Nrf2) protects the cell against oxidative damage. The Nrf2 system comprises a complex network that functions to ensure adequate responses to redox perturbations, but also metabolic demands and cellular ...
Ana Karina Aranda-Rivera, Alfredo Cruz-Gregorio, José Pedraza-Chaverri, Alexandra Scholze   +3 more
doaj   +1 more source

Opsoclonus in Pediatric Patients: Differential Diagnosis and a Practical Approach to Evaluation

Annals of the Child Neurology Society, EarlyView.
ABSTRACT Opsoclonus is an ocular dyskinesia characterized by involuntary, arrhythmic, multidirectional saccades. In pediatrics, opsoclonus is most commonly attributed to the rare neuroinflammatory disorder opsoclonus‐myoclonus‐ataxia syndrome (OMAS), typically considered a paraneoplastic syndrome associated with neural crest tumors. However, opsoclonus
Aubrey C. Reed, Supreet S. Randhawa, Jason H. Peragallo, Prabhumallikarjun Patil, Grace Gombolay, Varun Kannan   +5 more
wiley   +1 more source

Uremic Toxins and Mortality in Patients With Acute Kidney Injury Prior to and During Continuous Kidney Replacement Therapy

Kidney Medicine
Rationale & Objective: Uremia is an indication for continuous kidney replacement therapy (CKRT) in patients with acute kidney injury (AKI). Existing studies of uremic toxins in AKI have several limitations, including modest cohort sizes and small ...
Isadore M. Budnick, Samel Park, Kristy Rolloff, John T. Brinton, Julie A. Reisz, Daniel Stephenson, Sarah M. Haeger, Amanda Smith, Kayo Okamura, Zhibin He, Makoto Miyazaki, North Foulon, Matthew Kennis, David J. Madison, Rachel E. Blaine, Ruth Campbell, James F. Colbert, Diana I. Jalal, Benjamin R. Griffin, Yunus H. Ozekin, Sarah Faubel   +20 more
doaj   +1 more source

Heparin-induced thrombocytopenia following Shiga-toxin-associated hemolytic uremic syndrome: a case report

Journal of Medical Case Reports, 2022
Background Up to 50% of cases of Shiga-toxin-producing Escherichia coli hemolytic uremic syndrome occur in adults, and the clinical presentation is variable.
Elia Rigamonti, Tecla Bonora, Mariangela Ventresca, Pietro Cippà   +3 more
doaj   +1 more source